Hypertension in chronic kidney disease

Shivendra Singh
{"title":"Hypertension in chronic kidney disease","authors":"Shivendra Singh","doi":"10.1016/j.cqn.2013.02.003","DOIUrl":null,"url":null,"abstract":"<div><p><span>CKD is leading cause of secondary hypertension. Prevalence of hypertension in Indian urban population is appox. 20–40% whereas in CKD its prevalence is much higher depending on stage of CKD reaching about 90% in </span>ESRD<span>. Hypertension, besides proteinuria<span><span> is one of important factor in progression of CKD and CVD risk. Thus it has pivotal role in outcome of CKD and ESRD patients. Large number of studies has shown that effective control of blood pressure retards progression of renal disease and lower blood pressure targets have more favorable outcome, especially in proteinuric patients. The </span>cardiovascular mortality is much higher in CKD than general population, but there are no large studies in CKD population to ascertain optimal blood pressure in reducing cardiovascular mortality in this group. The understanding of hypertension and target blood pressure level to be achieved in CKD and ESRD patients in terms of retarding the progression of renal disease and reducing the CVD events in this population has been discussed with the available evidences.</span></span></p></div>","PeriodicalId":100275,"journal":{"name":"Clinical Queries: Nephrology","volume":"2 1","pages":"Pages 15-22"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cqn.2013.02.003","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Queries: Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211947713000071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

CKD is leading cause of secondary hypertension. Prevalence of hypertension in Indian urban population is appox. 20–40% whereas in CKD its prevalence is much higher depending on stage of CKD reaching about 90% in ESRD. Hypertension, besides proteinuria is one of important factor in progression of CKD and CVD risk. Thus it has pivotal role in outcome of CKD and ESRD patients. Large number of studies has shown that effective control of blood pressure retards progression of renal disease and lower blood pressure targets have more favorable outcome, especially in proteinuric patients. The cardiovascular mortality is much higher in CKD than general population, but there are no large studies in CKD population to ascertain optimal blood pressure in reducing cardiovascular mortality in this group. The understanding of hypertension and target blood pressure level to be achieved in CKD and ESRD patients in terms of retarding the progression of renal disease and reducing the CVD events in this population has been discussed with the available evidences.

慢性肾脏疾病中的高血压
慢性肾病是继发性高血压的主要原因。印度城市人口高血压患病率为appox。而在CKD中,根据CKD的分期,其患病率要高得多,在ESRD中约为90%。除蛋白尿外,高血压也是CKD和CVD发生的重要因素之一。因此,它在CKD和ESRD患者的预后中具有关键作用。大量研究表明,有效控制血压可以延缓肾脏疾病的进展,降低血压目标有更有利的结果,尤其是蛋白尿患者。CKD患者的心血管死亡率远高于一般人群,但目前还没有大型CKD人群的研究来确定最佳血压在降低该组心血管死亡率中的作用。关于CKD和ESRD患者在延缓肾脏疾病进展和减少CVD事件方面的高血压和目标血压水平的认识已经根据现有证据进行了讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信